PMID- 28804991 OWN - NLM STAT- MEDLINE DCOM- 20171106 LR - 20180119 IS - 2326-5205 (Electronic) IS - 2326-5191 (Linking) VI - 69 IP - 11 DP - 2017 Nov TI - NF-kappaB2 Controls the Migratory Activity of Memory T Cells by Regulating Expression of CXCR4 in a Mouse Model of Sjogren's Syndrome. PG - 2193-2202 LID - 10.1002/art.40230 [doi] AB - OBJECTIVE: Dysregulated chemokine signaling contributes to autoimmune diseases by facilitating aberrant T cell infiltration into target tissues, but the specific chemokines, receptors, and T cell populations remain largely unidentified. The aim of this study was to examine the role of the potent chemokine CXCL12 and its receptor CXCR4 in the T cell autoimmune response, using alymphoplasia (aly)/aly mice, a model of Sjogren's syndrome (SS). METHODS: T cell phenotypes in the salivary gland of aly/aly mice were evaluated using immunologic analysis. An in vitro migration assay was used to assess T cell migratory activity toward several chemokines. Gene expression of chemokine receptors and transforming growth factor beta receptors (TGFbetaRs) was measured by quantitative reverse transcription-polymerase chain reaction. The CXCR4 antagonist AMD3100 was administered to the aly/aly mice in order to evaluate its suppressive effect on autoimmune lesions. RESULTS: Effector memory T (TEM) cells derived from aly/aly mice demonstrated higher in vitro migratory activity toward CXCL12 than did TEM cells from aly/+ mice. CXCL12 expression was specifically up-regulated in the SS target cells of aly/aly mice. TEM cells from RelB(-/-) mice, but not Nfkb1(-/-) mice, also showed high migratory activity toward CXCL12, implicating a role of the nonclassical RelB/NF-kappaB2 pathway in the regulation of TEM cell migration. TEM cells from aly/aly mice also overexpressed TGFbetaR type I (TGFbetaRI) and TGFbetaRII. The CXCR4 antagonist AMD3100 suppressed autoimmune lesions in aly/aly mice by reducing TEM cell infiltration. CONCLUSION: Our results suggest that the RelB/NF-kappaB2 pathway regulates T cell migration to autoimmune targets through TGFbeta/TGFbetaR-dependent regulation of CXCL12/CXCR4 signaling. This suggests that these signaling pathways are potential therapeutic targets for the treatment of autoimmune diseases. CI - (c) 2017, American College of Rheumatology. FAU - Kurosawa, Mie AU - Kurosawa M AD - Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan. FAU - Arakaki, Rieko AU - Arakaki R AD - Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan. FAU - Yamada, Akiko AU - Yamada A AD - Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan. FAU - Tsunematsu, Takaaki AU - Tsunematsu T AD - Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan. FAU - Kudo, Yasusei AU - Kudo Y AD - Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan. FAU - Sprent, Jonathan AU - Sprent J AD - Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia. FAU - Ishimaru, Naozumi AU - Ishimaru N AD - Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20171017 PL - United States TA - Arthritis Rheumatol JT - Arthritis & rheumatology (Hoboken, N.J.) JID - 101623795 RN - 0 (CXCR4 protein, mouse) RN - 0 (Chemokine CXCL12) RN - 0 (Cxcl12 protein, mouse) RN - 0 (NF-kappa B p52 Subunit) RN - 0 (Nfkb2 protein, mouse) RN - 0 (Receptors, CXCR4) RN - 0 (Relb protein, mouse) RN - 147337-75-5 (Transcription Factor RelB) SB - IM MH - Animals MH - Chemokine CXCL12/immunology MH - Chemotaxis, Leukocyte/*genetics/immunology MH - Disease Models, Animal MH - Gene Expression Regulation MH - In Vitro Techniques MH - Mice MH - Mice, Knockout MH - NF-kappa B p52 Subunit/*genetics MH - Receptors, CXCR4/*genetics/immunology MH - Sjogren's Syndrome/*genetics/immunology MH - T-Lymphocytes/*immunology MH - Transcription Factor RelB/genetics EDAT- 2017/08/15 06:00 MHDA- 2017/11/07 06:00 CRDT- 2017/08/15 06:00 PHST- 2017/03/07 00:00 [received] PHST- 2017/08/09 00:00 [accepted] PHST- 2017/08/15 06:00 [pubmed] PHST- 2017/11/07 06:00 [medline] PHST- 2017/08/15 06:00 [entrez] AID - 10.1002/art.40230 [doi] PST - ppublish SO - Arthritis Rheumatol. 2017 Nov;69(11):2193-2202. doi: 10.1002/art.40230. Epub 2017 Oct 17.